<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Orally disintegrating and related dosage forms (eg, ODTs, dispersible films)*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Orally disintegrating and related dosage forms (eg, ODTs, dispersible films)*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Orally disintegrating and related dosage forms (eg, ODTs, dispersible films)*</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td colspan="2"><strong>NOTE:</strong> These formulations require swallowing; other formulations that are absorbed transmucosally and do not require swallowing (eg, sublingual, buccal) are provided in a separate table</td> </tr> <tr> <td class="subtitle1">Drug</td> <td class="subtitle1">Available strengths*</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Analgesic, antiinflammatory, antipyretic, antimigraine</td> </tr> <tr> <td class="indent1">Acetaminophen (paracetamol)</td> <td>80, 160 mg</td> </tr> <tr> <td class="indent1">Ibuprofen (ODT not available in United States)</td> <td>200 mg</td> </tr> <tr> <td class="indent1">Meloxicam</td> <td>7.5, 15 mg</td> </tr> <tr> <td class="indent1">Nimesulide (not available in United States)</td> <td>100 mg</td> </tr> <tr> <td class="indent1">Piroxicam (ODT not available in United States)</td> <td>20 mg</td> </tr> <tr> <td class="indent1">Rimegepant</td> <td>75 mg</td> </tr> <tr> <td class="indent1">Rizatriptan</td> <td>5, 10 mg</td> </tr> <tr> <td class="indent1">Tramadol (ODT not available in United States)</td> <td>50 mg</td> </tr> <tr> <td class="indent1">Zolmitriptan</td> <td>2.5, 5 mg</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Antidepressant</td> </tr> <tr> <td class="indent1">Escitalopram (ODT not available in United States)</td> <td>10, 20 mg</td> </tr> <tr> <td class="indent1">Mirtazapine</td> <td>15, 30, 45 mg</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Antihistamine</td> </tr> <tr> <td class="indent1">Cetirizine</td> <td>10 mg</td> </tr> <tr> <td class="indent1">Desloratadine</td> <td>2.5, 5 mg</td> </tr> <tr> <td class="indent1">Diphenhydramine</td> <td>12.5 mg (dispersible film)</td> </tr> <tr> <td class="indent1">Fexofenadine</td> <td>30 mg</td> </tr> <tr> <td class="indent1">Loratadine</td> <td>5, 10 mg</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Antipsychotic</td> </tr> <tr> <td class="indent1">Aripiprazole</td> <td>10, 15 mg</td> </tr> <tr> <td class="indent1">Clozapine</td> <td>12.5, 25, 100, 150, 200 mg</td> </tr> <tr> <td class="indent1">Olanzapine</td> <td>5, 10, 15, 20 mg</td> </tr> <tr> <td class="indent1">Risperidone</td> <td>0.25, 0.5, 1, 2, 3, 4 mg</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Cough and cold</td> </tr> <tr> <td class="indent1">Benzocaine</td> <td>6% (dispersible film, local effect)</td> </tr> <tr> <td class="indent1">Dextromethorphan</td> <td>7.5 mg (dispersible film)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Gastrointestinal</td> </tr> <tr> <td class="indent1">Famotidine (ODT not available in United States)</td> <td>20 mg</td> </tr> <tr> <td class="indent1">Glycopyrrolate</td> <td>1.7 mg</td> </tr> <tr> <td class="indent1">Hyoscyamine</td> <td>0.125 mg</td> </tr> <tr> <td class="indent1">Lansoprazole (delayed release)</td> <td>15, 30 mg</td> </tr> <tr> <td class="indent1">Loperamide (ODT not available in United States)</td> <td>2 mg</td> </tr> <tr> <td class="indent1">Metoclopramide</td> <td>5, 10 mg</td> </tr> <tr> <td class="indent1">Ondansetron</td> <td>4, 8 mg (ODT; dispersible film available in some countries other than United States)</td> </tr> <tr> <td class="indent1">Simethicone</td> <td>40, 62.5 mg (dispersible film)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Glucocorticoid</td> </tr> <tr> <td class="indent1">Prednisolone</td> <td>10, 15, 30 mg</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Neurologic</td> </tr> <tr> <td class="indent1">Alprazolam</td> <td>0.25, 0.5, 1, 2 mg</td> </tr> <tr> <td class="indent1">Amphetamine</td> <td>5, 10, 15, 20 mg</td> </tr> <tr> <td class="indent1">Amphetamine (extended release)</td> <td>3.1, 6.3, 9.4, 12.5, 15.7, 18.8 mg</td> </tr> <tr> <td class="indent1">Baclofen (granules in packets)</td> <td>5, 10, 20 mg</td> </tr> <tr> <td class="indent1">Clobazam</td> <td>5, 10, 20 mg</td> </tr> <tr> <td class="indent1">Carbidopa-levodopa</td> <td>10-100, 25-100, 25-250 mg</td> </tr> <tr> <td class="indent1">Clonazepam</td> <td>0.125, 0.25, 0.5, 1, 2 mg</td> </tr> <tr> <td class="indent1">Donepezil</td> <td>5, 10 mg</td> </tr> <tr> <td class="indent1">Fingolimod</td> <td>0.25, 0.5 mg</td> </tr> <tr> <td class="indent1">Lamotrigine</td> <td>25, 50, 100, 200 mg</td> </tr> <tr> <td class="indent1">Methylphenidate (extended release)</td> <td>8.6, 17.3, 25.9 mg</td> </tr> <tr> <td class="indent1">Riluzole</td> <td>50 mg (dispersible film)</td> </tr> <tr> <td class="indent1">Selegiline</td> <td>1.25 mg</td> </tr> <tr> <td class="indent1">Zolpidem</td> <td>5 mg/actuation (oral spray)</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Other</td> </tr> <tr> <td class="indent1">Vardenafil</td> <td>10 mg</td> </tr> </tbody></table></div><div class="graphic_lgnd"><p>Orally disintegrating (also known as orodispersible) tablets and films are designed to dissolve rapidly in saliva and provide a useful alternative to pills for patients with non-severe swallowing difficulties. The tablet or film is dissolved on top of the tongue and can be taken without water. This method of administration requires swallowing of dissolved pharmaceutical for adequate absorption and is not appropriate for use in patients with severe dysphagia.</p>
This is not an exhaustive list of orally disintegrating medications. For additional information including indications, dosage, and precautions, refer to the relevant clinical topics and Lexicomp drug monographs included within UpToDate.</div><div class="graphic_footnotes"><p>ODT: orally disintegrating tablet.</p>
* Strengths listed are for ODTs unless otherwise noted.</div><div class="graphic_reference">Data from Lexicomp Online. Copyright © 1978-2024 Lexicomp, Inc. All Rights Reserved.</div><div id="graphicVersion">Graphic 95668 Version 13.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
